285 SAMHSA-listed treatment centers in Maine. Free, confidential help available 24/7.
Browse 285 verified drug and alcohol treatment facilities in Maine. Each listing is sourced from federal databases and verified for accuracy. Use the information below to compare programs, verify insurance acceptance, and find the right facility for your needs.
Need help choosing? Call for free, confidential guidance from a treatment specialist.
Per CDC WONDER's latest reporting cycle, Maine sees 44.9 overdose deaths per 100,000 people — above the US average (32.6/100k). The full ASAM treatment continuum is represented on this page, with most listed facilities offering outpatient or IOP-level care and a meaningful minority providing residential or detox services.
Listings are sourced from the federal SAMHSA treatment locator and updated quarterly against state licensing-board records. No pay-for-placement.
The first 90 days after leaving treatment carry roughly 60% of total post-treatment relapse risk in Maine. The mitigation is structured aftercare — outpatient therapy, sober living, mutual-support, MAT if applicable, peer recovery.
Maintenance outpatient therapy following IOP/PHP discharge: weekly individual sessions, monthly medication review, monthly group if needed. Often Medicaid-covered.
Sober living homes bridge from residential treatment to independent living. Drug testing, house meetings, employment expectations. NARR certification is the Maine gold standard.
Multiple frameworks exist: AA, NA, SMART Recovery (cognitive), Refuge Recovery (Buddhist), LifeRing (secular), Celebrate Recovery (Christian). Try several; find fit.
Buprenorphine, methadone, or naltrexone should continue long-term for opioid-use disorder.
A growing component of Maine's recovery infrastructure: certified peer specialists who have lived experience and state credentials. Available through many Medicaid plans.
Naloxone (Narcan) is available without prescription at most Maine pharmacies under standing orders. Family training is the second piece — kit alone is not enough.
The first 90 days post-discharge are highest-risk. Daily community contact, scheduled therapy/coaching, MAT continuity, written relapse-response plan.
Treatment varies in intensity and structure but combines several evidence-based components. Knowing what is coming reduces first-week anxiety and improves engagement.
CBT teaches patients to recognize the cognitive distortions that precede use ("I deserve this," "one won't hurt") and replace them with reality-checked alternatives.
Used to build internal motivation during the first weeks. MI evokes the patient's own change-talk and amplifies it through reflective listening.
Medication-Assisted Treatment combines an FDA-approved medication with counseling. For opioid-use disorder, buprenorphine and methadone are the gold standard.
For patients whose substance use is in the service of regulating overwhelming emotion, DBT's skill-based approach often resonates more than insight-oriented therapies.
Untreated trauma is a major relapse driver. Modern addiction programs offer parallel or integrated trauma-focused therapy for the substantial trauma-affected subset.
Twelve-Step facilitation is an evidence-based clinical approach, distinct from AA/NA membership. Facility staff use it to introduce mutual-support concepts.
Under the federal Mental Health Parity and Addiction Equity Act, most insurance plans in Maine must cover substance-use treatment at parity with physical-health benefits.
Aetna · Anthem · Blue Cross Blue Shield · Cigna · Humana · Kaiser Permanente · UnitedHealthcare · Medicare · MaineCare · Tricare (military) · VA Community Care
In Maine, Medicaid is administered as MaineCare. State-licensed facilities are typically required to accept it for substance-use treatment. Verify eligibility at medicaid.gov.
Addiction is a family disease. Maine treatment centers increasingly include family programming because it materially improves treatment retention and post-discharge relapse rates.
Getting into addiction treatment in Maine is a sequence, not a single decision. Each facility runs a comparable five-step intake — initial call, benefits check, clinical assessment, planning, arrival — that on average takes 3–5 days from first inquiry to first day in care.
Lack of private insurance is a navigation challenge, not a wall. Maine has seven distinct funding pathways for addiction treatment — Medicaid, federal SAPT grants, VA, faith-based, drug courts, FQHC sliding-scale, payment plans.
| Level | Duration | OOP (insured) | Best fit |
|---|---|---|---|
| Medical detox | 3–7 days | $0–$3,000 | Severe alcohol/opioid withdrawal |
| Residential / Inpatient | 28–90 days | $0–$10,000 | Moderate-to-severe addiction, 24/7 structure needed |
| Partial Hospitalization (PHP) | 2–6 weeks | $0–$5,000 | 20+ hrs/wk structured care |
| Intensive Outpatient (IOP) | 8–12 weeks | $0–$2,500 | 9–19 hrs/wk, fits work/school |
| Standard Outpatient | 3–12+ months | $0–$1,500 | Aftercare or mild dependence |
Many Maine treatment centers offer tracks tailored to specific demographic or clinical populations. Match-fit matters: gender-specific or population-specific programs consistently show better retention than generic programming.
Trauma-informed care, pregnancy-aware medical management, parenting groups.
Emotion-regulation focus, anger management, fatherhood support, identity processing.
School integration, family therapy required, lower-intensity longer-duration models.
Combat-trauma-aware programming, VA Community Care eligibility, military culture competence.
Identity-affirming therapy, anti-discrimination policies, family-of-choice integration.
Psychiatry on staff, integrated treatment of depression/anxiety/PTSD/bipolar alongside substance use.
Nursing/physician recovery monitoring, confidential reporting, return-to-practice protocols.
Late-onset alcohol-use disorder, polypharmacy concerns, age-appropriate group composition.
All statistics and policy claims sourced from federal-government and peer-reviewed agencies. Last verified May 2026.
Treatment in Maine operates within layered systems — clinical (ASAM levels of care), regulatory (federal SAMHSA/FDA/DEA standards), financial (insurance/Medicaid/self-pay), and community (mutual support, recovery housing). The sections below outline each layer in practical terms relevant to patients and families making treatment decisions.
Family members in Maine navigating a loved one's active addiction can access support through Al-Anon, Nar-Anon, SMART Recovery Family & Friends, and CRAFT-based (Community Reinforcement and Family Training) programs. CRAFT specifically teaches evidence-based techniques for engaging a reluctant family member into treatment — research shows approximately 70% of CRAFT participants successfully engage their loved one into treatment within 3-6 months, substantially higher than traditional Al-Anon or interventionist approaches.
Relapse is statistically common in addiction recovery and does not signal treatment failure. National data suggests roughly 40-60% of patients experience at least one relapse within the first year post-treatment, similar to other chronic conditions like hypertension and diabetes. Maine treatment providers increasingly frame addiction as a chronic condition requiring long-term management rather than an acute episode with a cure. Relapse response should be immediate re-engagement with treatment at the appropriate level of care, NOT discharge from the recovery community.
Most Maine residents pay for addiction treatment through one of four channels: commercial insurance (employer-sponsored or marketplace), Medicaid, Medicare, or self-pay. Commercial plans typically require pre-authorization for residential treatment, with medical necessity demonstrated through ASAM criteria documentation. Medicaid coverage varies by Maine expansion status; the Medicaid agency in Maine maintains a list of in-network treatment providers. Medicare Part A covers inpatient residential when medically necessary; Part B covers outpatient. Self-pay arrangements are negotiable.
Co-occurring mental-health treatment is essential for many Maine patients. The epidemiology is well-established: roughly half of patients with substance-use disorders also have a diagnosable mental-health condition (depression, anxiety, PTSD, bipolar, ADHD, personality disorders). Sequential treatment (substance use first, then mental health) generally produces worse outcomes than integrated treatment (both conditions addressed simultaneously by an integrated team). Patients should ask prospective Maine providers explicitly about dual-diagnosis capacity.
Programs in Maine are structured around discrete levels of care that vary in clinical intensity and degree of supervision. Medically managed detox is reserved for high-risk withdrawal presentations. Residential treatment ranges from short-term (30 days) to extended care (90+ days). Partial hospitalization and intensive outpatient programs allow patients to live at home while engaging in 9-20+ structured hours per week. Standard outpatient continues recovery work at lower intensity, often indefinitely.
Maine addiction treatment operates within a federal regulatory framework set by SAMHSA, the FDA (medication approvals), the DEA (controlled-substance authority), and CMS (Medicare/Medicaid coverage rules). 42 CFR Part 2 governs the confidentiality of substance-use treatment records — stricter than HIPAA, requiring written patient consent for most disclosures. This means information about your treatment generally cannot be shared with employers, family members, or other providers without your written permission, with narrow exceptions for medical emergencies and child-abuse mandated reporting.